Younger age as a key predictor of follow‐up abandonment among PrEP users: A retrospective cohort study in Madrid
J. Mayoral‐Alvarez, Rubén Fernandez-Ibañez, Matilde Sánchez‐Conde, J. M. Hermida et autres
0 citationsHIV Medicine
Sergio Serrano‐Villar
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
191Publications signalées
5796Citations signalées
6Affiliations récentes
Institutions déclarées
Domaines associés
HIV-related health complications and treatmentsHIV Research and TreatmentHIV/AIDS Research and InterventionsGut microbiota and healthHIV/AIDS drug development and treatment
Publications récentes
Three-Year CD4/CD8 Ratio Recovery After Initiation of Dual Versus Triple Integrase Inhibitor–Based Therapy in Naïve Adults With HIV
Roser Navarro‐Soler, Alejandro García García, Juan Macı́as, Jorge Sanchez-Villegas et autres
0 citationsOpen Forum Infectious Diseases
Mediterranean diet adherence is associated with antiviral, neuroimmune, and cardiometabolic proteomic profiles in people with HIV
Mónica Manzano, Elena Moreno, Laura Martín-Pedraza, C. Vanesa Díaz-García et autres
3 citationsFrontiers in Nutrition
Interferon-Associated Inflammation and Galectin-9 Predict Risk of Non-AIDS Events and Mortality in Treated HIV
Sergio Serrano‐Villar, C. Vanesa Díaz-García, Laura Martín-Pedraza, Javier Martínez-Sanz et autres
0 citationsResearch Square
Beyond bacilli: integrating the microbiome into the TB research agenda
Edson Mambuque, Ana del Amo-de Palacios, Samuel G. Huete, Charissa C. Marsh et autres
1 citationGut Microbes
Intensification with a CCR5 inhibitor at antiretroviral therapy initiation modulates interleukin-18 and inflammation-driven immune pathways in people with HIV
Erick De La Torre Tarazona, Sergio Calderón-Vicente, María Fons-Contreras, Marta Rava et autres
1 citationInternational Journal of Infectious Diseases
Clarifying INSTINCT: Switching From Dolutegravir/Lamivudine to Bictegravir/Emtricitabine/Tenofovir Shows Comparable Inflammatory and Weight Outcomes
Sergio Serrano‐Villar, Santiago Moreno
0 citationsClinical Infectious Diseases
Weight Gain Among Children and Adolescents on Dolutegravir in Spain
Blanca Bravo, Luis Manuel Prieto Tato, Antoni Noguera‐Julián, Luis Escosa‐García et autres
0 citationsJournal of the Pediatric Infectious Diseases Society
Cervical microbiota diversity and functional shifts in the development of cervical high-grade squamous intraepithelial lesions
Marta Rosas Cancio-Suárez, Elena Moreno, Cristina del Valle Rubido, M.D. Salvador et autres
0 citationsFrontiers in Medicine
Comparable Inflammatory and Metabolic Outcomes After Switching to Bictegravir/Emtricitabine/Tenofovir Alafenamide Versus Continuing Dolutegravir/Lamivudine in Virologically Suppressed Adults With HIV (INSTINCT/GESIDA10918 Study)
Sergio Serrano‐Villar, Laura Martín‐Pedraza, Juan Tiraboschi, María Novella et autres
7 citationsClinical Infectious Diseases
Two or Three? Clinical and Proteomic Perspectives on Dolutegravir/Lamivudine Versus Bictegravir/Emtricitabine/Tenofovir Alafenamide as Initial HIV Treatment
C. Vanesa Díaz-García, Sergio Serrano‐Villar, Alejandro García García, Robert Güerri‐Fernández et autres
1 citationOpen Forum Infectious Diseases
Identification of Inflammation Markers as Novel Potential Predictors of the HIV-DNA Reservoir Size
Erick De La Torre Tarazona, Elisa Moraga, María Fons-Contreras, Raúl Vaquer et autres
2 citationsInternational Journal of Molecular Sciences
BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.